| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Technical Advance |

§

§

§
From the Departments of Molecular and Medical Genetics*
and Laboratory Medicine and Pathobiology,
University of Toronto, and the Samuel Lunenfeld Research
Institute
and Department of Pathology and
Laboratory Medicine,§
Mount Sinai Hospital,
Toronto, Ontario, Canada
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Strategies for isolating pure RNA involve a number of steps, which can lead to degradation, and a lower recovery of an already limited amount of RNA. To overcome this we have modified a recent method,6 describing RT-PCR analysis of cell line mRNA without RNA isolation, for the purpose of analyzing mRNA derived from microdissected regions of cryostat tumor sections. Briefly, microdissected cells are lysed by cycles of freeze-thaw to release RNA into a solution designed to minimize degradation. RT-PCR can be performed using the RNA solution without any additional processing. Using this method, we amplified different size fragments of the ß2-microglobulin (ß2m) gene mRNA transcript from microdissected regions of frozen breast carcinoma sections. As well, the methodology was used for amplification of BRCA1 and p21Waf1 cDNAs. The effects of different section thickness and various tissue staining dyes on the efficiency of RT-PCR were also assessed in the study.
| Materials and Methods |
|---|
|
|
|---|
A block of fresh tissue (approximately 1 x 1 x 0.5 cm
breast carcinoma or skin) was snap frozen in liquid nitrogen as close
as possible to the time of surgical removal and stored at -70°C. The
tissue block was embedded in OCT, and frozen sections were cut in a
Reichert-Jung 2800 Figocut E cryostat. A single section of the frozen
tissue was placed on a 2% agarose-coated glass slide and stained with
1% methylene blue or Harris's hematoxylin (unless specified
otherwise) for 10 seconds and rinsed with water. Two 24-gauge needles
were used to microdissect specific regions from the sections (Figure 1)
. The microdissected regions were
immediately placed in a pre-chilled Eppendorf tube that was kept on ice
at all times to minimize degradation.
|
To the Eppendorf tube containing the microdissected tissue, 10 µl of freezing solution (0.15 mol/L NaCl, 10 mmol/L Tris, pH 8.0, 5 U of RNase inhibitor, 0.25 mmol/L dithiothreitol) was immediately added. In comparison with the published report,6 we have used a smaller quantity of both RNase inhibitor and dithiothreitol, and to minimize any potential RNA degradation, we have included these reagents in the freezing solution rather than adding them after the cells have already been suspended. The tube was immediately frozen in an ethanol/dry ice bath and rapidly thawed in a 37°C water bath for at least two to three cycles of freeze-thaw to lyse the cells.
RT-PCR Analysis
The freeze-thawed cell suspension was briefly centrifuged to sediment cellular debris. The RNA-containing supernatant was used as template in a RT-PCR to amplify different fragments from the ß2m (267, 448, and 629 bp), BRCA1 (458 bp), and p21Waf1 (545 bp) mRNA transcripts. PCR primers were designed to target different exons of the gene to ensure the expected PCR products were derived from mRNA template and not from contaminating genomic DNA. As well, we used human genomic DNA as template in PCR amplification to confirm that the product was not due to pseudogene sequences. For cDNA synthesis, 2.9 µl of the supernant was incubated at 37°C for 1 hour in an 8-µl reaction containing 50 mmol/L Tris/HCl (pH 8.3), 75 mmol/L KCl, 3 mmol/L MgCl2, 10 mmol/L dithiothreitol, 500 mmol/L of each dNTP, 40 ng of random hexamers, 4 U of RNase inhibitor, and 20 U of Moloney murine reverse transcriptase. We have supplied additional RNase inhibitor to the cDNA reaction as its activity can be inactivated by the freeze-thawing.6 PCR amplification of ß2m was performed in a 12-µl reaction, containing 2 µl of the cDNA mix, 1X PCR buffer (10 mmol/L Tris/HCl, pH 8.3, 50 mmol/L KCl, 0.01% (w/v) gelatin), 112.5 µmol/L of each dNTP (Pharmacia Biotech, Piscataway, NJ), 1.0 mmol/L MgCl2, 0.75 mmol/L of each primer, and 1 U of AmpliTaq polymerase (Perkin Elmer, Norwalk, CT). For different size fragments, different combinations of primers were used: ß2m1 (5' ACC CCC ACT GAA AAA GAT GA 3') and ß2m3 (5' GGA GAC AGC ACT CAA AGT AG 3') for the 267-bp fragment, ß2m4 (5' CTC ACG TCA TCC AGC AGA GA 3') and ß2m3 for the 448-bp fragment, and ß2m4 and ß2m5 (5' CAA GCT TTG AGT GCA AGA GA 3') for the 629-bp fragment. Amplification proceeded for either 35 or 40 cycles of 15 seconds at 94°C, 15 seconds at 56°C, and 20 seconds at 72°C in the Perkin Elmer 9600. PCR amplification of BRCA1 and p21Waf1 were performed in a 20-µl volume containing 2 µl of the cDNA mix, 1X PCR buffer, MgCl2 (0.8 mmol/L for BRCA1 and 0.9 mmol/L for p21Waf1), 100 µmol/L of each dNTP, 0.45 µmol/L of each primer, and 1 U of AmpliTaq polymerase. Primers used to amplify BRCA1 cDNA were BRCA13F (5' AGC AGA GGG ATA CCA TGC 3') and BRCA16R (5' CAA ATC GTG TGG CCC AGA CT 3'); primers used to amplify p21Waf1 cDNA were LinkA (5' GCC GGA GCT GGG CGC GGA TT 3') and Got-2 (5' GGC TTC CTC TTG GAG AAG AT 3'). Amplification proceeded for either 35 or 40 cycles of 20 seconds at 94°C, 15 seconds at 56°C (for p21Waf1) or 58°C (for BRCA1), and 25 seconds at 72°C in the Perkin Elmer 9600. PCR products were visualized on a 2% agarose gel stained with eithidium bromide.
| Results |
|---|
|
|
|---|
We successfully amplified a 267-bp region of the ß2m
mRNA transcript using RNA from the supernatant of freeze-thawed
microdissected cell suspensions as template. Figure 2
shows the ability to perform RT-PCR on
microdissected regions with an area as small as 1 x 1 mm, the
approximate size of a microdissected area of ductal carcinoma in
situ. All sets of RT-PCRs contained negative controls for freezing
buffer, cDNA synthesis, and PCR amplification to ensure that there was
no contamination. In an attempt to increase the yield of RNA without
having to expand the area of microdissection, we compared RT-PCR
results of microdissected regions from sections of 20 µm (Figure 2A)
and 40 µm (Figure 2B)
in thickness. There was no significant
difference in intensity of the ß2m RT-PCR product.
|
|
|
To further validate the methodology we designed primers specific
to the p21Waf1 and BRCA1 cDNAs. Both
p21Waf1 and BRCA1 play important
roles in breast cancer and are expressed at a lower level than
ß2m. Nonetheless, a product as large as 545 bp of the
p21Waf1 (Figure 5A)
and 458 bp of the
BRCA1 (Figure 5B)
mRNA transcripts was successfully
amplified from microdissected specimens.
|
To microdissect a region containing a specific cell type from a
heterogeneous tissue, it is important to be able to recognize tissue
architecture. A number of water-soluble dyes are available for the
purpose of tissue staining, with the choice of dye depending on the
specific tissue attribute of interest. To determine whether the choice
of dye for tissue staining can interfere with RT-PCR, we added to a
cell line RNA, an equal volume of serially diluted methylene blue (1%;
Fisher Scientific, Fairlawn, NJ), Harris's alum hematoxylin (undiluted
and filtered; Harleco, EM Diagnostic Systems, Gibbstown, NJ), light
green (1%; BDH, Poole, UK), and neutral red (1%; Sigma, St. Louis,
MO) before the RT-PCR assay (Figure 6)
.
For Harris's hematoxylin, we found that there was no inhibition of
RT-PCR until dye concentration exceeded 0.05% (1 in 2000 dilution from
undiluted stock). In contrast, no RT-PCR product could be detected
using methylene blue, light green, and neutral red at any concentration
greater than 0.01%. We suspect that the amount of dye remaining on the
tissue is lower than these inhibitory concentrations because the
section is thoroughly rinsed with water after staining. In fact, when
using either methylene blue (Figure 2A)
or Harris's hematoxylin
(Figure 2C)
for tissue staining, we did not observe any difference in
efficiency of RT-PCR.
|
| Discussion |
|---|
|
|
|---|
Although thicker sections (40 µm) contain more cells per unit area, they did not appear to provide more available RNA template as judged by the intensity of RT-PCR product. This may be due a lower lysing efficiency for cells lying in the center of the section. Sections of 20 µm may be the thickness of choice as they are technically easier to prepare and manipulate, as well as allowing for more sections to be cut from each block.
To microdissect tissue accurately it is necessary to stain the tissue to allow tissue architecture to be discerned. We found that at high concentration the four water-soluble dyes studied can inhibit the RT-PCR. However, in practice, this should not be a concern as tissues are stained briefly and washed in water to remove most of the dye.
In summary, we have described a method for analyzing mRNA transcripts from microdissected frozen tissue sections without the need for RNA isolation. The method can be used to study gene expression and mRNA structure and sequence in a histologically confirmed homogeneous cell population. This allows the opportunity to study RNA in small lesions that cannot be grossly identified. In addition to a variety of human cancers, the method can also be applied to other areas of research, such as developmental biology to allow for an analysis of specific mRNA from different cell types within a developing embryo. In particular, we have found the methodology works equally well with microdissected epidermal cells from a section of skin (data not shown). With the methodology described here, there is the potential to correlate expression levels of mRNA, as well as structural variations, with particular histological phenotypes.
| Footnotes |
|---|
Supported in part by grants from the Canadian Breast Cancer Research Initiative and the National Cancer Institute of Canada (M. Redston and I.L. Andrulis). S.J. Done is a Research Fellow of the National Cancer Institute of Canada supported with funds provided by the Terry Fox Run.
Accepted for publication April 24, 1998.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. Doleshal, A. A. Magotra, B. Choudhury, B. D. Cannon, E. Labourier, and A. E. Szafranska Evaluation and Validation of Total RNA Extraction Methods for MicroRNA Expression Analyses in Formalin-Fixed, Paraffin-Embedded Tissues J. Mol. Diagn., May 1, 2008; 10(3): 203 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Craven, N. Totty, P. Harnden, P. J. Selby, and R. E. Banks Laser Capture Microdissection and Two-Dimensional Polyacrylamide Gel Electrophoresis : Evaluation of Tissue Preparation and Sample Limitations Am. J. Pathol., March 1, 2002; 160(3): 815 - 822. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Fend and M. Raffeld Laser capture microdissection in pathology J. Clin. Pathol., September 1, 2000; 53(9): 666 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Serth, M. A. Kuczyk, U. Paeslack, R. Lichtinghagen, and U. Jonas Quantitation of DNA Extracted after Micropreparation of Cells from Frozen and Formalin-Fixed Tissue Sections Am. J. Pathol., April 1, 2000; 156(4): 1189 - 1196. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Fend, M. R. Emmert-Buck, R. Chuaqui, K. Cole, J. Lee, L. A. Liotta, and M. Raffeld Immuno-LCM: Laser Capture Microdissection of Immunostained Frozen Sections for mRNA Analysis Am. J. Pathol., January 1, 1999; 154(1): 61 - 66. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |